Stockreport

Applied Therapeutics Announces Full Data and Scientific Presentations from the Pivotal Phase 2 ACTION-Galactosemia Trial

Applied Therapeutics, Inc.  (APLT) 
Last applied therapeutics, inc. earnings: 11/13 07:00 am Check Earnings Report
PDF AT-007 demonstrated rapid and sustained reduction in toxic galactitol levels with no accompanying increase in galactose Positive trend on MRI outcomes, including indire [Read more]